Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 18/20 | 0.45 |
| ▸ | CTSL | P07711 | 16/20 | 0.45 |
| ▸ | CTSS | P25774 | 15/20 | 0.45 |
| ▸ | ITGAV | P06756 | 1/20 | 0.35 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6475720 | 0.92 | CTSK (0.44) | CTSKCTSLCTSSITGAVITGA2 | |
| SCHEMBL6476642 | 0.91 | CTSK (0.49) | CTSKCTSLCTSS | |
| SCHEMBL6476085 | 0.91 | CTSL (0.56) | CTSKCTSLCTSS | |
| SCHEMBL6476830 | 0.88 | CTSK (0.50) | CTSKCTSLCTSS | |
| SCHEMBL6475961 | 0.88 | CTSK (0.46) | CTSKCTSLCTSSITGAVITGA2 | |
| SCHEMBL6484312 | 0.87 | CTSK (0.57) | CTSKCTSLCTSS | |
| SCHEMBL6475452 | 0.87 | CTSL (0.47) | CTSKCTSLCTSS | |
| SCHEMBL6589053 | 0.86 | CTSK (0.37) | CTSKCTSLCTSS | |
| SCHEMBL6476274 | 0.86 | CTSL (0.46) | CTSKCTSLCTSS | |
| SCHEMBL6485754 | 0.85 | CTSK (0.44) | CTSKCTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050020588-A1 | Cysteine protease inhibitors | PEPTIMMUNE, INC. | 2005-01-27 | — | — | US | claimed |
| US-20050020588-A1 | Cysteine protease inhibitors | PEPTIMMUNE, INC. | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020588-A1 | Cysteine protease inhibitors | CTSS, CTSE, CTSV | CTSK 4/4885CTSL 11/4885CTSS 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.